Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer

The goal of this clinical trial is to compare two dose schedules of stereotactic radiation therapy in patients with localized prostate cancer. Historically, external beam radiation to treat localized prostate cancer was given in small treatments over a period of multiple weeks. Recent studies have shown that with newer technologies and better understanding of how prostate cancer responds to radiation, the same effective dose can be given in as few as 5 treatments. This study is comparing this newer standard course of 5 treatments with an even shorter course of just 2 treatments. The dose for t

Trial Details

NCT ID
NCT06027892
Phase
NA
Sponsor
Rabin Medical Center
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Two-fraction stereotactic radiotherapy
  • Five-fraction stereotactic radiotherapy
Locations (sample)
  • Petah Tikva, Israel, Israel|32.08707,34.88747

Key Eligibility Criteria

  • Male patients ≥18 years
  • Diagnosis of low- or favorable intermediate-risk prostate adenocarcinoma
  • Prostate specific antigen \< 20
  • Gleason 6 or 7 (3+4)

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →